Belatacept reduces skin cancer risk in kidney transplant recipients.

J Am Acad Dermatol

Department of Dermatology, Yale New Haven Hospital, Yale School of Medicine, New Haven, Connecticut; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Electronic address:

Published: April 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.09.070DOI Listing

Publication Analysis

Top Keywords

belatacept reduces
4
reduces skin
4
skin cancer
4
cancer risk
4
risk kidney
4
kidney transplant
4
transplant recipients
4
belatacept
1
skin
1
cancer
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!